Illumina, Inc. (ILMN) Free Cash Flow
Illumina, Inc. (ILMN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $508.00M |
| 2017-12-31 | $563.00M |
| 2018-12-31 | $846.00M |
| 2019-12-31 | $842.00M |
| 2020-12-31 | $891.00M |
| 2021-12-31 | $337.00M |
| 2022-12-31 | $106.00M |
| 2023-12-31 | $283.00M |
| 2024-12-31 | $709.00M |
| 2025-12-31 | $931.00M |
How ILMN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| UTHR | United Therapeutics Corporation | $1.04B |
| NBIX | Neurocrine Biosciences Inc. | $748.70M |
| BMRN | BioMarin Pharmaceutical Inc. | $717.02M |
| HSIC | Henry Schein Inc. | $573.00M |
| ENSG | The Ensign Group Inc. | $564.27M |
These are five companies in the same sector as ILMN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Illumina, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ILMN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ILMN | $273.04 | +2.75% | 2.84M |
| 3 | ||||
| 4 | ||||
| 5 |